Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis
OBJECTIVE: To determine whether cotrimoxazole reduces mortality in adults receiving antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection in low- and middle-income countries through a systematic review and meta-analysis. METHODS: PubMed and Embase were searched for randomized...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The World Health Organization
2012-02-01
|
Series: | Bulletin of the World Health Organization |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862012000200013&lng=en&tlng=en |
_version_ | 1797281856472743936 |
---|---|
author | Amitabh B Suthar Reuben Granich Jonathan Mermin Annelies Van Rie |
author_facet | Amitabh B Suthar Reuben Granich Jonathan Mermin Annelies Van Rie |
author_sort | Amitabh B Suthar |
collection | DOAJ |
description | OBJECTIVE: To determine whether cotrimoxazole reduces mortality in adults receiving antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection in low- and middle-income countries through a systematic review and meta-analysis. METHODS: PubMed and Embase were searched for randomized controlled trials and prospective and retrospective cohort studies that compared mortality or morbidity in HIV-infected individuals aged > 13 years on cotrimoxazole and ART and on ART alone. The Newcastle- Ottawa Quality Assessment Scale was used to assess selection, confounding and measurement bias. Publication bias was assessed using Egger's and Begg's tests. Sensitivity analysis was performed because the I-squared statistic indicated substantial heterogeneity in study results. A random-effects model was used for meta-analysis. FINDINGS: Nine studies were included. Begg and Egger P-values for the seven that reported the effect of cotrimoxazole on mortality were 0.29 and 0.49, respectively, suggesting no publication bias. The I-squared statistic was 93.2%, indicating high heterogeneity in study results. The sensitivity analysis showed that neither the follow-up duration nor the percentage of individuals with World Health Organization stage 3 or 4 HIV disease at baseline explained the heterogeneity. The summary estimate of the effect of cotrimoxazole on the incidence rate of death was 0.42 (95% confidence interval: 0.29-0.61). Since most studies followed participants for less than 1 year, it was not possible to determine whether cotrimoxazole can be stopped safely after ART-induced immune reconstitution. CONCLUSION: Cotrimoxazole significantly increased survival in HIV-infected adults on ART. Further research is needed to determine the optimum duration of cotrimoxazole treatment in these patients. |
first_indexed | 2024-03-07T17:03:29Z |
format | Article |
id | doaj.art-058a9de5a2c646a897154da2d2d03ec5 |
institution | Directory Open Access Journal |
issn | 0042-9686 |
language | English |
last_indexed | 2024-03-07T17:03:29Z |
publishDate | 2012-02-01 |
publisher | The World Health Organization |
record_format | Article |
series | Bulletin of the World Health Organization |
spelling | doaj.art-058a9de5a2c646a897154da2d2d03ec52024-03-03T02:56:17ZengThe World Health OrganizationBulletin of the World Health Organization0042-96862012-02-01902128138S0042-96862012000200013Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysisAmitabh B Suthar0Reuben Granich1Jonathan Mermin2Annelies Van Rie3University of North CarolinaWorld Health OrganizationCenters for Disease Control and PreventionUniversity of North CarolinaOBJECTIVE: To determine whether cotrimoxazole reduces mortality in adults receiving antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection in low- and middle-income countries through a systematic review and meta-analysis. METHODS: PubMed and Embase were searched for randomized controlled trials and prospective and retrospective cohort studies that compared mortality or morbidity in HIV-infected individuals aged > 13 years on cotrimoxazole and ART and on ART alone. The Newcastle- Ottawa Quality Assessment Scale was used to assess selection, confounding and measurement bias. Publication bias was assessed using Egger's and Begg's tests. Sensitivity analysis was performed because the I-squared statistic indicated substantial heterogeneity in study results. A random-effects model was used for meta-analysis. FINDINGS: Nine studies were included. Begg and Egger P-values for the seven that reported the effect of cotrimoxazole on mortality were 0.29 and 0.49, respectively, suggesting no publication bias. The I-squared statistic was 93.2%, indicating high heterogeneity in study results. The sensitivity analysis showed that neither the follow-up duration nor the percentage of individuals with World Health Organization stage 3 or 4 HIV disease at baseline explained the heterogeneity. The summary estimate of the effect of cotrimoxazole on the incidence rate of death was 0.42 (95% confidence interval: 0.29-0.61). Since most studies followed participants for less than 1 year, it was not possible to determine whether cotrimoxazole can be stopped safely after ART-induced immune reconstitution. CONCLUSION: Cotrimoxazole significantly increased survival in HIV-infected adults on ART. Further research is needed to determine the optimum duration of cotrimoxazole treatment in these patients.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862012000200013&lng=en&tlng=en |
spellingShingle | Amitabh B Suthar Reuben Granich Jonathan Mermin Annelies Van Rie Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis Bulletin of the World Health Organization |
title | Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis |
title_full | Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis |
title_fullStr | Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis |
title_full_unstemmed | Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis |
title_short | Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis |
title_sort | effect of cotrimoxazole on mortality in hiv infected adults on antiretroviral therapy a systematic review and meta analysis |
url | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862012000200013&lng=en&tlng=en |
work_keys_str_mv | AT amitabhbsuthar effectofcotrimoxazoleonmortalityinhivinfectedadultsonantiretroviraltherapyasystematicreviewandmetaanalysis AT reubengranich effectofcotrimoxazoleonmortalityinhivinfectedadultsonantiretroviraltherapyasystematicreviewandmetaanalysis AT jonathanmermin effectofcotrimoxazoleonmortalityinhivinfectedadultsonantiretroviraltherapyasystematicreviewandmetaanalysis AT anneliesvanrie effectofcotrimoxazoleonmortalityinhivinfectedadultsonantiretroviraltherapyasystematicreviewandmetaanalysis |